PPD

MARCH 26, 2024

The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization.

Clinical Research 98

Clinical Research Pharmaceutical Companies Clinical Development Drug Development 98

DrugBank

OCTOBER 4, 2024

These structures are particularly relevant in dealing with uncertainty about the future commercial potential of the target's products. Emerging Markets Emerging markets, particularly in Asia and Latin America, have become increasingly attractive destinations for pharmaceutical M&A activity.

Pharmaceuticals 98

Pharmaceuticals Pharmaceutical Companies Therapies Marketing 98

DrugBank

MARCH 7, 2024

The Quest for Ozempic-Like Alternatives Ozempic, a GLP-1 receptor agonist developed by Novo Nordisk, has demonstrated remarkable efficacy in promoting weight loss and improving metabolic health. Key Players and Challenges For pharmaceutical giants like Novo Nordisk and Eli Lilly, 2024 presents both opportunities and challenges.

Pharmaceutical Companies 98

Pharmaceutical Companies Clinical Trials Pharmaceuticals Therapies 98

Drug Target Review

JANUARY 8, 2024

We are at the forefront of drug development in an area of research called cellular rejuvenation, which is an approach that has the potential to address many diseases of ageing by restoring aged and injured cells to a more youthful and resilient state. a commercial stage pharmaceutical company.

Science 145

Science Disease FDA Approval Clinical Trials 145

Drug Target Review

DECEMBER 11, 2024

This issue poses a significant hurdle for drug developers, with no universal protocol currently in place to address these complexities. Purity and radioactive enrichment are key factors in ensuring the IS aligns with product specifications.

International 52

International Laboratories Drugs Pharmacokinetics 52

DS in Pharmatics

FEBRUARY 24, 2023

Drug development is an immensely complex undertaking consisting of many different, interconnected processes. Specialist regulatory affairs consultants offer services to companies operating across this challenging industry.

Pharmaceutical Companies 52

Pharmaceutical Companies Regulations Drug Development Pharmaceuticals 52

Altus Drug Development

JUNE 30, 2022

A focus on customers has always been one of the main pillars of the pharmaceutical industry. However, this is often narrowed down to the creation of product-centric marketing strategies with a strong customer orientation. A reduction in drug pipelines coupled with poor flexibility in drug manufacturing.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment Production 52

H1 Blog

JULY 30, 2024

Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. This, in turn, provides crucial insights that help ensure the medical product’s safe and effective use among patients.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

Altus Drug Development

JUNE 28, 2022

Ensuring access to safe and effective treatments is the main challenge faced by pharmaceutical companies big and small. Value-added medicines offer an efficient method to meet the needs of patients while stimulating innovation in the pharmaceutical industry. Changes in the blood concentration profile of a drug.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

FDA Law Blog: Drug Discovery

MARCH 6, 2024

The American Conference Institute (“ACI”) will be hosting a series of go-to forums on critical topics including novel therapeutics, cosmetics/personal care products and Paragraph IV disputes. Claud will be featured at the Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products in New York, NY.

FDA 59

FDA Compliance Pharmaceuticals Pharmaceutical Companies 59

PPD

JULY 20, 2023

Industry guidelines require biopharmaceutical and biotechnology companies to test their pharmaceutical packaging systems, as the systems often experience prolonged and intimate contact with drug products, drug substances and intermediates. Recently, a major U.S.

Packaging 52

Packaging Laboratories Pharmaceutical Companies Compliance 52

H1 Blog

JUNE 8, 2023

In this blog post, we’ll explore how early diversity in HCP engagement can drive better outcomes and equity in drug development. The drug development process is known to be often expensive, lengthy, and full of trial and error before finding success.

Drug Development 52

Drug Development Science Pharmaceutical Companies Production 52

DrugBank

JANUARY 22, 2025

Environmental Impacts of Traditional Pharmaceutical Production Traditional pharmaceutical manufacturing is complex, with each phase contributing to environmental degradation. The extraction and synthesis of active pharmaceutical ingredients (API) utilize vast amounts of water and energy.

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies Production Government 52

Drug Target Review

MAY 23, 2023

For instance, microbial fermentation products such as branched-chain fatty acids can increase inflammation and contribute to the development of IBD, 5,6 while bacterial fermentation products such as short-chain fatty acids are known to benefit gut health by restoring the gut microbiota’s natural state.

Drugs 75

Drugs Small Molecule Production Disease 75

The Connected Lab

JUNE 2, 2021

Exploring how digital transformation will revolutionize process optimization and decision-making within the pharmaceutical industry Networked digital technologies and advanced automation are transforming pharmaceutical manufacturing , enabling efficiencies through real-time process optimization and faster decision-making. value chain.

Pharmaceuticals 52

Pharmaceuticals Laboratories Pharmaceutical Companies Production 52

Advarra

AUGUST 16, 2022

The Orphan Drug Act of 1983 was instrumental in changing the number of orphan drugs approved in the U.S. The law established the Office of Orphan Products Development , providing financial incentives for pharmaceutical companies to develop orphan drugs and making it more viable to invest in orphan drug research and development.

Disease 52

Disease Clinical Trials FDA Approval FDA 52

Altus Drug Development

MAY 31, 2022

From natural health products to life-saving medicines, all pharmaceutical products must undergo an analytical method development process. Through analytical method development, validation, and transfer, drug development and manufacturing are kept safe, efficient, and compliant with the law.

Pharmaceuticals 52

Pharmaceuticals Clinical Trials Production Drug Development 52

DrugBank

DECEMBER 18, 2024

DTx presents a unique opportunity for pharmaceutical companies to diversify their product portfolios and create new revenue streams. DTx can streamline drug development by enabling more targeted and effective therapies. DTx can streamline drug development by enabling more targeted and effective therapies.

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies Treatment Therapies 52

Drug Target Review

JUNE 19, 2024

Also, many companies never reached the point where they received validation from big pharmaceutical companies. We look at that long list and ask which of the cell types looks attractive to us as a potential product. Mr Culley served on the Board of Orphagen Pharmaceuticals, Inc. from May 2017 until December 2022.

Therapies 84

Therapies Small Molecule Pharmaceutical Companies Molecular Biology 84

Perficient: Drug Development

AUGUST 20, 2024

Companies must keep track of a plethora of items, ensuring that they are properly categorized, tracked, and managed. Oracle Product Data Hub (PDH) Cloud and Oracle Inventory Management Cloud are two powerful tools that work in tandem to achieve these goals. Industry-specific Attributes: Chemicals, electronics, pharmaceuticals, etc.

Compliance 52

Compliance Production Pharmaceutical Companies Pharmaceuticals 52

The Pharma Data

NOVEMBER 10, 2020

Growing into a biopharmaceutical company, Innovent has built an integrated platform covering from drug discovery, CMC, clinical development and commercialization. By joining Innovent, Dr. Liu will be responsible for global R & D, pipeline strategy, business development and international operations.

Biosimilars 52

Biosimilars Clinical Trials International Clinical Development 52

Conversations in Drug Development Trends

MAY 14, 2024

Patients navigating life with rare diseases are experts in their own right, and they offer a unique resource for CROs and pharmaceutical companies to help support study success. Common goals empower change. Every patient counts In the realm of rare diseases, our focus is on unique and precious opportunities.

Disease 81

Disease Clinical Trials Trials Pharmaceutical Companies 81

Predictive Oncology

FEBRUARY 7, 2023

That means a lot of wasted effort and resources for drugmakers given that even before a molecule enters Phase I trials, typically five to eight years of development have already been invested in the product. The next step was to validate the predictions and learn whether the drugs really produce a response in the specific tumor type.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

The Pharma Data

JANUARY 24, 2021

“We are excited to welcome Chris, a highly regarded drug developer and team builder who brings to Notch great depth of experience and expertise in development of cell therapies, gene editing, and cell engineering spanning discovery through IND,” said David Main , President and Chief Executive Officer of Notch.

Science 52

Science Engineering Therapies Pharmaceutical Companies 52

The Pharma Data

MARCH 20, 2021

Natural language processing (NLP) has long held potential for the life sciences field, given the industry’s reliance on text-based data in the form of clinical records, scientific papers, pharmaceutical companies’ call center transcriptions and so forth.

Science 40

Science Pharmaceutical Companies Compliance Drug Development 40

The Pharma Data

DECEMBER 28, 2020

Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Annamycin for treatment of soft tissue sarcomas. .

FDA 52

FDA Clinical Trials Drugs Pharmaceutical Companies 52

NIH Director's Blog: Drug Development

FEBRUARY 27, 2018

More than 90 percent of that contributory research was basic—that is, related to the discovery of fundamental biological mechanisms, rather than actual development of the drugs themselves. Previous attempts to quantify the contribution of federal funding to new drug development had looked primarily at patents.

Research 52

Research Science FDA Pharmaceutical Companies 52

PPD

NOVEMBER 21, 2022

Which attributes and features of the patient experience should pharmaceutical companies prioritize to strengthen customer relationships? Are patients open to follow-up interactions from pharmaceutical companies? “I was very satisfied with how well the product worked and the results.”

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Pharmaceuticals Production 52

The Pharma Data

DECEMBER 31, 2020

where he led global clinical development programs including clinical strategy, clinical development, and regulatory affairs. He also previously served as Global CMO at Taiho Pharmaceutical Company, Ltd. He also held roles at Onyx Pharmaceuticals, Millennium Pharmaceuticals, Roche and Bristol-Myers Squibb.

Engineering 52

Engineering Pharmaceuticals Clinical Development Virus 52

The Connected Lab

MAY 31, 2022

Driven by technologies such as advanced automation, smart sensors, artificial intelligence and machine learning, digital transformation provides new opportunities for organizations to streamline workflows, boost productivity and improve quality throughout the value chain.

Laboratory Informatics 52

Laboratory Informatics Laboratories Compliance Pharmaceuticals 52

The Connected Lab

APRIL 8, 2020

If we think about research in more traditional areas such as oncology, gastroenterology, and CNS disorders where large amounts of data have already been produced, AI, ML, and DL can help discover new compounds that could become new drugs, uncover or repurpose drugs, and improve the area of personalized medicine.

Pharma Companies 52

Pharma Companies Laboratories Drugs FDA Approval 52

The Pharma Data

DECEMBER 8, 2020

AbCellera’s AI-powered antibody discovery platform speeds the otherwise lengthy and grueling process by analyzing the database of natural immune systems to find antibodies that can be developed into drugs. Tackle the toughest problems in drug development.” The promise to partners is to “move quickly. Reduce cost.

RNA 52

RNA Therapies Disease Protein Expression 52

Molecule Blog

MARCH 17, 2023

For instance, many of the top-selling therapeutics available today were originally developed in academia and had to navigate the difficult path of translation. The process of transforming a therapeutic or technology from the research and development stage into a market-ready product or service is intricate and laden with obstacles.

Engineering 52

Engineering Research Clinical Trials Government 52

Conversations in Drug Development Trends

MAY 23, 2024

Navigating Advanced Therapy Medicinal Products (ATMPs) in the EU: Regulatory Challenges : The EU has an overall regulatory framework for ATMPs , Regulation (EC) No 1394/2007. These designs allow for evaluating multiple drugs or treatments simultaneously, offering a more flexible and efficient approach to drug development.

Trials 52

Trials Clinical Trials Therapies Treatment 52

The Pharma Data

DECEMBER 28, 2020

Hofstein has also played key leadership roles in establishing industry partnerships and strategic alliances with leading global biopharmaceutical, biotechnology and pharmaceutical companies, including Amgen, Baxter, Celgene, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer and Takeda. Dr. Hofstein received his B.Sc.

Pharmaceuticals 52

Pharmaceuticals Pharmaceutical Companies Government Therapies 52

Drug Target Review

SEPTEMBER 19, 2024

Could you give us an overview of IRLAB’s current drug development pipeline? According to IRLAB’s calculations, the probability that an ISP-generated drug will reach pivotal Phase III studies is almost three times higher than for a drug developed with traditional methods – 20 percent compared to seven percent.

Disease 52

Disease Drugs Treatment Drug Development 52

The Pharma Data

JANUARY 27, 2021

28, 2021 /PRNewswire/ — CASI Pharmaceuticals (Formerly Known As EntreMed, Inc.). The Company’s validated, proprietary F.I.R.S.T About CASI Pharmaceuticals. CASI Pharmaceuticals, Inc. . ROCKVILLE, Md. , and BEIJING , Jan. Nasdaq: CASI), a U.S. NASDAQ: CASI) is a U.S.

Pharmaceuticals 52

Pharmaceuticals Clinical Trials Licensing Licensing 52